Detalhe da pesquisa
1.
[111In]In-CP04 as a novel cholecystokinin-2 receptor ligand with theranostic potential in patients with progressive or metastatic medullary thyroid cancer: final results of a GRAN-T-MTC Phase I clinical trial.
Eur J Nucl Med Mol Imaging
; 50(3): 892-907, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36334104
2.
67Cu Production Capabilities: A Mini Review.
Molecules
; 27(5)2022 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35268600
3.
Design and Evaluation of 223Ra-Labeled and Anti-PSMA Targeted NaA Nanozeolites for Prostate Cancer Therapy-Part II. Toxicity, Pharmacokinetics and Biodistribution.
Int J Mol Sci
; 22(11)2021 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34071854
4.
PSMA-D4 Radioligand for Targeted Therapy of Prostate Cancer: Synthesis, Characteristics and Preliminary Assessment of Biological Properties.
Int J Mol Sci
; 22(5)2021 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33800517
5.
Tandem peptide receptor radionuclide therapy using 90Y/177Lu-DOTATATE for neuroendocrine tumors efficacy and side-effects - polish multicenter experience.
Eur J Nucl Med Mol Imaging
; 47(4): 922-933, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31980909
6.
Radiometals for imaging and theranostics, current production, and future perspectives.
J Labelled Comp Radiopharm
; 62(10): 615-634, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31137083
7.
Clinical translation of theranostic radiopharmaceuticals: Current regulatory status and recent examples.
J Labelled Comp Radiopharm
; 62(10): 673-683, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30741441
8.
Comparison of 99mTc radiolabeled somatostatin antagonist with [68 Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor.
Eur J Nucl Med Mol Imaging
; 50(13): 4110-4111, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37452871
9.
177Lu Labeled Cyclic Minigastrin Analogues with Therapeutic Activity in CCK2R Expressing Tumors: Preclinical Evaluation of a Kit Formulation.
Mol Pharm
; 14(9): 3045-3058, 2017 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28728415
10.
Comparison of PET/CT imaging with [18F]FDOPA and cholecystokinin-2 receptor targeting [68Ga]Ga-DOTA-MGS5 in a patient with advanced medullary thyroid carcinoma.
Eur J Nucl Med Mol Imaging
; 48(3): 935-936, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32748048
11.
A one-step automated synthesis of the dopamine transporter ligand [(18)F]FECNT from the chlorinated precursor.
J Labelled Comp Radiopharm
; 59(3): 82-6, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26853227
12.
Initial study of radiological and clinical efficacy radioembolization using 188Re-human serum albumin (HSA) microspheres in patients with progressive, unresectable primary or secondary liver cancers.
Med Sci Monit
; 20: 1353-62, 2014 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25086245
13.
Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC- 99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma.
Eur J Nucl Med Mol Imaging
; 40(4): 524-31, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23224740
14.
Polish experience in Peptide receptor radionuclide therapy.
Recent Results Cancer Res
; 194: 467-78, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-22918776
15.
Development of the 99mTc-Labelled SST2 Antagonist TECANT-1 for a First-in-Man Multicentre Clinical Study.
Pharmaceutics
; 15(3)2023 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36986746
16.
Imaging of inflamed carotid artery atherosclerotic plaques with the use of 99mTc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients.
Eur J Nucl Med Mol Imaging
; 39(4): 673-82, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22237843
17.
Bioorthogonal Chemistry Approach for the Theranostics of GRPR-Expressing Cancers.
Pharmaceutics
; 14(12)2022 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36559063
18.
Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals.
EJNMMI Radiopharm Chem
; 7(1): 18, 2022 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35852679
19.
Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
EJNMMI Radiopharm Chem
; 7(1): 25, 2022 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36182995
20.
Clinical results of radionuclide therapy of neuroendocrine tumours with 90Y-DOTATATE and tandem 90Y/177Lu-DOTATATE: which is a better therapy option?
Eur J Nucl Med Mol Imaging
; 38(10): 1788-97, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21553086